Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Cogstate Limited
  6. Summary
    CGS   AU000000CGS8

COGSTATE LIMITED

(CGS)
  Report
Delayed Australian Stock Exchange  -  02:10 2022-08-09 am EDT
1.800 AUD    0.00%
07/27TRANSCRIPT : Cogstate Limited, Q4 2022 Earnings Call, Jul 28, 2022
CI
07/27COGSTATE : Business Update and June 2022 Quarter Cashflow
PU
06/20COGSTATE : Joins New Collaborative of Global Healthcare Leaders to Define Core Digital Measures for Alzheimer's Disease
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
08/03/2022 08/04/2022 08/05/2022 08/08/2022 08/09/2022 Date
1.85(c) 1.85(c) 1.825(c) 1.8(c) 1.8 Last
266 933 106 423 63 043 498 433 197 423 Volume
+1.65% 0.00% -1.35% -1.37% 0.00% Change
More quotes
Estimated financial data (e)
Sales 2022 65,3 M 45,7 M 45,7 M
Net income 2022 11,3 M 7,88 M 7,88 M
Net cash position 2022 38,2 M 26,8 M 26,8 M
P/E ratio 2022 27,6x
Yield 2022 -
Sales 2023 78,5 M 55,0 M 55,0 M
Net income 2023 13,3 M 9,30 M 9,30 M
Net cash position 2023 48,0 M 33,6 M 33,6 M
P/E ratio 2023 23,4x
Yield 2023 -
Capitalization 312 M 218 M 218 M
EV / Sales 2022 4,19x
EV / Sales 2023 3,36x
Nbr of Employees 171
Free-Float 47,0%
More Financials
Company
Cogstate Ltd is an Australia-based neuroscience technology company. The Company optimizes brain health assessments to develop new medicines and to enable earlier clinical insights in healthcare. The Company’s technologies provide computerized cognitive tests across a list of domains and support electronic clinical outcome assessment (eCOA) solutions. The Company operates through two segments: Clinical Trials and... 
Read more
More about the company
All news about COGSTATE LIMITED
07/27TRANSCRIPT : Cogstate Limited, Q4 2022 Earnings Call, Jul 28, 2022
CI
07/27COGSTATE : Business Update and June 2022 Quarter Cashflow
PU
06/20COGSTATE : Joins New Collaborative of Global Healthcare Leaders to Define Core Digital Mea..
PU
06/14Cogstate Announces Formation of Scientific Advisory Board
GL
06/14Cogstate Announces Formation of Scientific Advisory Board
CI
06/14COGSTATE : Announces Formation of Scientific Advisory Board
PU
05/26Cogstate Ltd. Announces Change of Registered Office and Principal Place of Business
CI
04/20COGSTATE : Investor Update
PU
04/20COGSTATE : Business Update and March 2022 Quarter Cashflow
PU
03/20COGSTATE LIMITED(ASX : CGS) added to S&P/ASX All Ordinaries Index
CI
03/20COGSTATE LIMITED(ASX : CGS) added to S&P/ASX Emerging Companies Index
CI
02/24TRANSCRIPT : Cogstate Limited, H1 2022 Earnings Call, Feb 24, 2022
CI
02/23COGSTATE : Half Year Report – H1 FY2022
PU
02/23COGSTATE : 1H22 Financial Results & Business Update
PU
02/23COGSTATE : Investor Briefing
PU
More news
News in other languages on COGSTATE LIMITED
06/14Cogstate annonce la formation d'un conseil consultatif scientifique
02/23Cogstate Limited annonce ses résultats pour le semestre clos le 31 décembre 2021
01/20Cogstate enregistre une hausse de 40 % de son chiffre d'affaires au deuxième trimestre ..
01/12Cogstate commercialise sa technologie directement auprès des consommateurs à Taïwan et ..
2021Cogstate réalise un bénéfice pour l'exercice 21 grâce à une hausse du chiffre d'affaire..
More news
Chart COGSTATE LIMITED
Duration : Period :
Cogstate Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COGSTATE LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,80 AUD
Average target price 2,46 AUD
Spread / Average Target 36,9%
EPS Revisions
Managers and Directors
Bradley John O'Connor Chief Executive Officer, Executive Director & MD
Darren Watson Chief Financial Officer
Martyn Kenneth Myer Non-Executive Chairman
Chris Edgar Chief Scientific Officer
Benjamin Bloomfield Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
COGSTATE LIMITED-25.62%218
MODERNA, INC.-26.44%73 092
IQVIA HOLDINGS INC.-16.80%43 781
LONZA GROUP AG-26.44%43 083
SEAGEN INC.13.72%32 426
ALNYLAM PHARMACEUTICALS, INC.28.89%26 235